RYK and prostate cancer: Whether RYK amplification is a pathogenic variant in prostate cancer is currently unknown, however, RYK over-expression in mouse fibroblasts induces anchorage-independent growth in vitro and increases tumorgenicity in vivo [129], supporting an oncogenic role.